ALPHABATICAL TEST LIST MODIFICATIONS

Size: px
Start display at page:

Download "ALPHABATICAL TEST LIST MODIFICATIONS"

Transcription

1 Issue : 3; Rev 1 Rev Date : 1/7/ N054 ANEUPLOIDY, BLOOD N053 ANEUPLOIDY, AMNIOTIC FLUID N055 ANEUPLOIDY, PRODUCTS OF CONCEPTION OS182 SCA 1 (SPINO CEREBELLAR ATAXIA), PCR FRAGMENT ANALYSIS H180 PROTEIN S, Test modifications (test details) Test Name PROTEIN S, FUNCTIONAL PROTEIN S ACTIVITY, FUNCTIONAL FUNCTIONAL H180 PROTEIN S, Test modifications (test details) Method Electromechanical Clot Detection Photo optical Clot Detection FUNCTIONAL OS184 SCA 3 (SPINO CEREBELLAR ATAXIA), PCR FRAGMENT ANALYSIS H101 ANTITHROMBIN ACTIVITY, FUNCTIONAL Test modifications (test details) Method Photo optical clot detection Chromogenic OS185 SCA 6 (SPINO CEREBELLAR ATAXIA), PCR FRAGMENT ANALYSIS OS186 SCA 7 (SPINO CEREBELLAR ATAXIA), PCR FRAGMENT ANALYSIS OS183 SCA 2 (SPINO CEREBELLAR ATAXIA), PCR FRAGMENT ANALYSIS S243 MuSK (MUSCLE SPECIFIC KINASE) ANTIBODY Test modifications (test details) Sample by Fri 9 am; report Next Sample by Tues 9 am; Next S231 FECAL CALPROTECTIN Test modifications (test details) Sample by Mon 9 am; Same R100 DHEA; Test modifications (test details) Sample by Tue 9 am; Same DEHYDROEPIANDROST ERONE S255 PHOSPHOLIPASE A2 RECEPTOR ANTIBODY (PLA2R), QUANTITATIVE H240 FACTOR VIII FUNCTIONAL / ACTIVITY H240 FACTOR VIII FUNCTIONAL / ACTIVITY Test modifications (test details) Sample by Mon / Thu 9 am ; Same Sample by Mon/ Thu 9 am; Same Sample by Tue/ Fri 9 am; Same Sample by Thu 9 am ; Same Test modifications (test details) Test Name FACTOR VIII FUNCTIONAL FACTOR VIII FUNCTIONAL / ACTIVITY Test modifications (test details) Method Photo Optical Clot Detection Electromechanical Clot Detection

2 Issue : 3; Rev 1 Rev Date : 1/7/ H240 FACTOR VIII FUNCTIONAL / ACTIVITY H240 FACTOR VIII FUNCTIONAL / ACTIVITY U035 METANEPHRINES, 24 HOUR URINE U052 METANEPHRINES, RANDOM URINE Z537 LEUKEMIA DIAGNOSTIC 2 Test modifications (test details) Price Rs 1,40000 Rs 1,80000 Test modifications (test details) Sample by Wed / Sat 9 am; Fri / Tue Sample Daily by 11 am; Same Test modifications (test details) Sample by Fri 9 am; Tue Sample by Wed / Sat 9 am, Fri HPLC / Tue Test modifications (test details) Sample by Fri 9 am; on Tue Sample by Wed / Sat 9 am, Fri HPLC / Tue Z601 LEUKEMIA DIAGNOSTIC Z663 LEUKEMIA DIAGNOSTIC, ANY 6 MARKERS Test modifications (test details) Test Name LEUKEMIA DIAGNOSTIC 7 LEUKEMIA DIAGNOSTIC, ANY 6 MARKERS Z664 LEUKEMIA DIAGNOSTIC M213 ADENOVIRUS ANTIGEN FOR RESPIRATORY INFECTIONS N061 GENEXPERT MTB WITH RIFAMPICIN RESISTANCE, QUALITATIVE, PCR S240 PHOSPHOLIPASE A2 RECEPTOR ANTIBODY (PLA2R) QUALITATIVE S240 PHOSPHOLIPASE A2 RECEPTOR ANTIBODY (PLA2R) QUALITATIVE N106 DNA ANALYSIS FOR PATERNITY TESTING N115 **DNA ANALYSIS FOR PATERNAL Y CHROMOSOME Test modifications (test details) Specimen 5 g fresh STOOL in a sterile screw capped container Ship refrigerated only DO NOT FREEZE Submit Nasal swab/nasophyrangeal secretion in a sterile screw capped container ship refrigerated only DO NOT FREEZE MICROBIOLOGY Test modifications (test details) Price Rs 2,00000 Rs 2,20000 Test modifications (test details) Test Name PHOSPHOLIPASE A2 RECEPTOR ANTIBODY (PLA2R) PHOSPHOLIPASE A2 RECEPTOR ANTIBODY (PLA2R) QUALITATIVE IMMUNOPATHOLOGY Test modifications (test details) Price Rs 6,20000 Rs 4,40000 IMMUNOPATHOLOGY Test modifications (test details) Sample Daily by 11 am; 10 Test modifications (test details) Sample Daily by 11 am; 12 Sample Daily by 11 am; 5 Sample Daily by 11 am; S109 **ANTI NUCLEAR ANTIBODY / FACTOR (ANA / ANF), IFA (HEP 2) IN DILUTIONS Test modifications (test details) Price Rs 2,90000 Rs 2,00000 IMMUNOPATHOLOGY Z665 LEUKEMIA DIAGNOSTIC

3 Issue : 3; Rev 1 Rev Date : 1/7/ G133 **PRENATAL DIAGNOSIS PANEL 1, CHORIONIC VILLUS BIOPSY G134 **PRENATAL DIAGNOSIS PANEL 2, AMNIOTIC FLUID N107 **DNA ANALYSIS FOR KINSHIP TESTING N068 HAINS MYCOBACTERIUM TUBERCULOSIS FIRST LINE DRUG RESISTANCE S044 ANTI NUCLEAR ANTIBODY / FACTOR (ANA / ANF), IFA (HEP 2) END POINT TITRE GENETICS GENETICS Test modifications (test details) Sample Daily by 11 am; 10 Sample Daily by 11 am; 5 Test modifications (test details) Price Rs 1,75000 Rs 1,80000 IMMUNOPATHOLOGY Z518 GENEXPERTCOM Test modifications (test details) Price Rs 2,70000 Rs 2, RW261 PIGEON DROPPINGS, OS IgE XX024 **FISH Bladder cancer CYTOGENETICS recurrence: Chromosomes 3,7, 17 & p16 gene on chromosome RW163 PYRIDINIUM OS COLLAGEN CROSS LINKS (PYD), 2 HOUR URINE Z144 PHEOCHROMOCYTOM Test modifications (test details) Method High Performance Liquid High Performance Liquid HPLC A Chromatography, EIA Chromatography, TRACE Z144 PHEOCHROMOCYTOM Test modifications (test details) Sample by Fri 9 am; Tue Sample by Wed/Sat 9 am; 2 HPLC A H252 PROTEIN S (FREE) Test modifications (test details) Test Name PROTEINS(FREE)ANTIGEN PROTEIN S (FREE) ANTIGEN ANTIGEN Z056 DEEP VEIN Test modifications (test details) Method Electromechanical & Photo optical Clot Chromogenic, Immunoturbidimetry, THROMBOSIS PANEL; DVT PANEL Detection, EIA Electromechanical Clot Detection & EIA Z056 DEEP VEIN THROMBOSIS PANEL; DVT PANEL Test modifications (test details) Price Rs 12,20000 Rs 13, Z056 DEEP VEIN THROMBOSIS PANEL; DVT PANEL Z056 DEEP VEIN THROMBOSIS PANEL; DVT PANEL Test modifications (test details) Sample by Wed 7 am; Fri Sample Daily by 3 pm; Next Test modifications (test details) Comments It is recommended that patient discontinues Heparin for 1 and Oral Anticoagulants for 7 prior to sampling as these drugs may affect test results Discontinuation should be with prior consent from the It is recommended that patient discontinues Heparin for 1 and Oral Anticoagulants for 7 prior to sampling as these drugs may affect test results Discontinuation should be with prior consent from the

4 Issue : 3; Rev 1 Rev Date : 1/7/ Z056 DEEP VEIN THROMBOSIS PANEL; DVT PANEL Z056 DEEP VEIN THROMBOSIS PANEL; DVT PANEL Z056 DEEP VEIN THROMBOSIS PANEL; DVT PANEL Z056 DEEP VEIN THROMBOSIS PANEL; DVT PANEL Z056 DEEP VEIN THROMBOSIS PANEL; DVT PANEL H246 THROMBOTIC RISK SCREEN H246 THROMBOTIC RISK SCREEN H246 THROMBOTIC RISK SCREEN H246 THROMBOTIC RISK SCREEN H246 THROMBOTIC RISK SCREEN treating Physician treating Physician Test modifications (test details) Usage Deep vein thrombosis (DVT) is one of Deep vein thrombosis (DVT) is one of the three major cardiovascular causes the three major cardiovascular causes of death along with Myocardial of death along with Myocardial infarction and Stroke The three infarction and Stroke The three common factors leading to DVT are common factors leading to DVT are venous stasis, hypercoagulability, and venous stasis, hypercoagulability, and changes in the endothelial blood changes in the endothelial blood vessel lining (such as physical damage vessel lining (such as physical damage or endothelial activation) contribute or endothelial activation) contribute to DVT and are used to explain its to DVT and are used to explain its formation formation Test modifications (test details) DoctorSpeciality H00009 H00009 Test modifications (test details) Components *Antithrombin Activity Functional *CardiolipinAntibodies IgG and IgM *drvvt *Protein C Functional *Protein S Functional *Antithrombin Activity Functional *Cardiolipin Antibodies IgG and IgM *drvvt *Protein C Functional * Protein S (free) antigen Test modifications (test details) PreTestInfo Overnight fasting is preferred Give brief clinical history It is recommended that patient discontinues Heparin for 1 and Oral Anticoagulants for 7 prior to sampling as these drugs may affect test results Discontinuation should be with prior coç Overnight fasting is preferred Give brief clinical history It is recommended that patient discontinues Heparin for 1 and Oral Anticoagulants for 7 prior to sampling as these drugs may affect test results Discontinuation should be with prior coç Test modifications (test details) DiseaseCode D00022 D00022 Test modifications (test details) Method Electromechanical & Photo optical Clot Chromogenic, Immunoturbidimetry & Detection Electromechanical Clot Detection Test modifications (test details) Price Rs 12,50000 Rs 13,00000 Test modifications (test details) Sample by 2nd / 4th Sat 11 am; Next Fri Test modifications (test details) Comments It is recommended that patient discontinues Heparin for 1 and Oral Anticoagulants for 7 prior to sampling as these drugs may affect test results Discontinuation should be with prior consent from the treating Physician Test modifications (test details) Usage An imbalance between procoagulant system and regulatory mechanisms can cause excessive fibrin production leading to Thrombosis These imbalances can be genetic or acquired or due to a combination of both leading to excessive fibrin formation at the site of injury with vessel occlusion and thrombus formation Major risk factor for arterial thrombosis is Sample by Wed 9 am ; Next It is recommended that patient discontinues Heparin for 1 and Oral Anticoagulants for 7 prior to sampling as these drugs may affect test results Discontinuation should be with prior consent from the treating Physician An imbalance between procoagulant system and regulatory mechanisms can cause excessive fibrin production leading to Thrombosis These imbalances can be genetic or acquired or due to a combination of both leading to excessive fibrin formation at the site of injury with vessel occlusion and thrombus formation Major risk factor for arterial thrombosis is

5 Issue : 3; Rev 1 Rev Date : 1/7/ H246 THROMBOTIC RISK SCREEN H246 THROMBOTIC RISK SCREEN H246 THROMBOTIC RISK SCREEN H246 THROMBOTIC RISK SCREEN Z319 THROMBOPHILIA Z319 THROMBOPHILIA Z319 THROMBOPHILIA Z319 THROMBOPHILIA Z319 THROMBOPHILIA Z319 THROMBOPHILIA atherosclerosis while for venous thrombosis, the risk factors include immobility, surgery, malignancy, hormone therapy, obesity and genetic factors atherosclerosis while for venous thrombosis, the risk factors include immobility, surgery, malignancy, hormone therapy, obesity and genetic factors Test modifications (test details) DoctorSpeciality H00009 H00009 Test modifications (test details) Components *Protein C Functional *Protein S Functional *Antithrombin Activity Functional *APCR Test modifications (test details) PreTestInfo Overnight fasting is preferred It is recommended that patient discontinues Heparin for 1 and Oral Anticoagulants for 7 prior to sampling as these drugs may affect test results Discontinuation should be with prior consent from the treating PhysÇ *Protein C Functional * Protein S (free) antigen *Antithrombin Activity Functional *APCR Overnight fasting is preferred It is recommended that patient discontinues Heparin for 1 and Oral Anticoagulants for 7 prior to sampling as these drugs may affect test results Discontinuation should be with prior consent from the treating PhysÇ Test modifications (test details) DiseaseCode D00022 D00022 Test modifications (test details) Method Electromechanical & Photo optical Clot Chromogenic, Immunoturbidimetry & Detection, PCR PCR Test modifications (test details) Price Rs 14,50000 Rs 15,00000 Test modifications (test details) Sample by Wed 6 pm; on Sat Sample by Mon / Thu 11 am; Wed / Sat Test modifications (test details) Comments It is recommended that patient It is recommended that patient discontinues Heparin for 1 and discontinues Heparin for 1 and Oral Anticoagulants for 7 prior to Oral Anticoagulants for 7 prior to sampling as these drugs may affect sampling as these drugs may affect test results Discontinuation should test results Discontinuation should be with prior consent from the treating be with prior consent from the treating Physician Physician Test modifications (test details) Usage Thrombophilia evaluations are usually performed to assess the need to extend anticoagulation, hence testing should be performed in a steady state, remote from the acute event Laboratory assays to detect thrombophilic states include highly sensitive and specific tests like molecular diagnosis, immunologic and functional assays Many coagulation factors and inhibitors are affected during acute thrombosis, acute illnesses, inflammatory conditions, pregnancy & certain medications Antithrombin is decreased by heparin and acute thrombosis whereas protein C & S levels are increased during acute thrombosis, but decreased by warfarin Thrombophilia evaluations are usually performed to assess the need to extend anticoagulation, hence testing should be performed in a steady state, remote from the acute event Laboratory assays to detect thrombophilic states include highly sensitive and specific tests like molecular diagnosis, immunologic and functional assays Many coagulation factors and inhibitors are affected during acute thrombosis, acute illnesses, inflammatory conditions, pregnancy & certain medications Antithrombin is decreased by heparin and acute thrombosis whereas protein C & S levels are increased during acute thrombosis, but decreased by warfarin Test modifications (test details) DoctorSpeciality H00009 H00009

6 Issue : 3; Rev 1 Rev Date : 1/7/ Z319 THROMBOPHILIA Z319 THROMBOPHILIA Z319 THROMBOPHILIA Z619 AUTOIMMUNE HEPATITIS PANEL Z619 AUTOIMMUNE HEPATITIS PANEL RW122 LIPID ASSOCIATED SIALIC ACID; LASA Z497 THROMBOPHILIA Z497 THROMBOPHILIA Z497 THROMBOPHILIA Z497 THROMBOPHILIA H061 PROTEIN C, FUNCTIONAL H101 ANTITHROMBIN ACTIVITY, FUNCTIONAL H180 PROTEIN S, FUNCTIONAL U099 5 AMINOLEVULINIC ACID (5 ALA), 24 HOURS, URINE S253 AUTO IMMUNE ENCEPHALITIS PANEL Test modifications (test details) Components *Protein C, Functional *Protein S, Functional *Antithrombin Activity Functional *Factor V Leiden Mutation *Prothrombin Gene Mutation *MTHFR gene mutation *Protein C, Functional * Protein S (free) antigen *Antithrombin Activity Functional *Factor V Leiden Mutation *Prothrombin Gene Mutation *MTHFR gene mutation Test modifications (test details) PreTestInfo Overnight fasting is preferred It is recommended that patient discontinues Heparin for 1 and Oral Anticoagulants for 7 prior to sampling as these drugs may affect test results Discontinuation should be with prior consent from the treating PhysÇ Overnight fasting is preferred It is recommended that patient discontinues Heparin for 1 and Oral Anticoagulants for 7 prior to sampling as these drugs may affect test results Discontinuation should be with prior consent from the treating Physician Test modifications (test details) DiseaseCode D00022 D00022 Test modifications (test details) Method Immunofluorescence Assay Immunofluorescence Assay IMMUNOPATHOLOGY Test modifications (test details) Sample Daily by 11 am; Same Test modifications (test details) Method Electromechanical & Photo optical Clot Detection, PCR Sample Daily by 11 am; Next Chromogenic, Immunoturbidimetry, Electromechanical Clot Detection & PCR IMMUNOPATHOLOGY OS Test modifications (test details) Price Rs 15,80000 Rs 16,50000 Test modifications (test details) Sample by Wed 6 pm; on Sat Sample by Mon / Thu 11 am; Wed / Sat Test modifications (test details) Components *Protein C, Functional *Protein S, Functional *Antithrombin Activity Functional *Factor V Leiden Mutation *Prothrombin Gene Mutation *MTHFR gene mutation *Lupus anticoagulant *Protein C, Functional * Protein S (free) antigen *Antithrombin Activity Functional *Factor V Leiden Mutation *Prothrombin Gene Mutation *MTHFR gene mutation *Lupus anticoagulant Test modifications (test details) Sample by Thu 9 am; Next Sample by 11 am; Same Test modifications (test details) Sample by Thu 9 am; Next Sample by 11 am; Same Test modifications (test details) Test Name 5 AMINOLEVULINIC ACID (5 ALA), QUANTITATIVE, URINE Test modifications (test details) Specimen 2 ml (005 ml Min)Serum 1 Tube SST AND 1 ml CSF in a sterile screw capped container Ship refrigerated or frozen Overnight fasting is preferred 5 AMINOLEVULINIC ACID (5 ALA), 24 HOURS, URINE 2 ml (05 ml min) Serum from 1 SST OR 1 ml (05 ml min) CSF in a sterile screw capped container Ship refrigerated or frozen Overnight fasting is preferred IMMUNOPATHOLOGY S253 AUTO IMMUNE Test modifications (test details) Sample by 2nd & 4th Wed 9 Sample by Thu 11 am; Next IMMUNOPATHOLOGY ENCEPHALITIS PANEL am; next H046 ANTI A TITRE, IgM Test modifications (test details) Test Name ANTI A TITRE ANTI A TITRE, IgM IMMUNOPATHOLOGY H046 ANTI A TITRE, IgM Test modifications (test details) Method Tube Agglutination Erythrocytes Magnetized Technology IMMUNOPATHOLOGY

7 Issue : 3; Rev 1 Rev Date : 1/7/ H047 ANTI B TITRE, IgM Test modifications (test details) Test Name ANTI B TITRE ANTI B TITRE, IgM IMMUNOPATHOLOGY H047 ANTI B TITRE, IgM Test modifications (test details) Method Tube Agglutination Erythrocytes Magnetized Technology IMMUNOPATHOLOGY N097 CANCER 50 GENE PANEL, NGS Test modifications (test details) Price Rs 40,00000 Rs 30, S235 ANTI NUCLEAR ANTIBODY / FACTOR (ANA / ANF), IFA (HEP 2) REFLEX TO ENA Test modifications (test details) Method Immunofluorescence Assay (Hep 2 Substrate) Line Immunoassay Immunofluorescence Assay (Hep 2 Substrate), Immunoblot IMMUNOPATHOLOGY S235 ANTI NUCLEAR ANTIBODY / FACTOR (ANA / ANF), IFA (HEP 2) REFLEX TO ENA Z855 PRE TRANSPLANT WORKUP NON SENSITIZED RECIPIENT PANEL 1 Test modifications (test details) Sample Daily by 11 am; Next Sample Mon through Sat by 11 am; Next IMMUNOPATHOLOGY L005 AB (CLASS 1) TYPING L006 DR (CLASS II) TYPING N023 DNA TYPING FOR KIDNEY / LIVER TRANSPLANT, PCR L018 DR & DQB1 (CLASS II) TYPING Z857 PRE TRANSPLANT WORKUP PANEL Z860 PRE TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL B196 GLUCOSE TOLERANCE TEST (GTT), PREGNANCY, 100g GLUCOSE Z873 PRE TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL 3 Test modifications (test details) Specimen 2 ml (1 ml min) plasma from 1 Grey Top (Sodium Fluoride) tube for each timed specimen Draw baseline fasting specimen Dissolve 100 g of glucose in 300 ml wateradminister orally over a period of 5 minutes Draw additional specimens at 10, 20 & 30 hrs Note time drawn on each container label and test request form Overnight fasting is mandatory Ship refrigerated or frozen 2 ml (1 ml min) plasma from 1 Grey Top (Sodium Fluoride) tube for each timed specimen Draw baseline fasting specimen Dissolve 110 g of glucose monohydrate in 300 ml water Administer orally over a period of 5 minutes Draw additional specimens at 10, 20 & 30 hrs Note time drawn on each container label and test request form Overnight fasting is mandatory Ship refrigerated or frozen G004 GLUCOSE CHALLENGE TEST (GCT); GLUCOSE 1 HOUR OBSTETRICAL Test modifications (test details) Specimen 2 ml (1 ml min) plasma from 1 Grey Top (Sodium Fluoride) tube drawn 1 hour after oral administration of 50 g glucose Does 2 ml (1 ml min) plasma from 1 Grey Top (Sodium Fluoride) tube drawn 1 hour after oral administration of 55 g glucose

8 Issue : 3; Rev 1 Rev Date : 1/7/ Z858 PRE TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL 4 not include a fasting specimen Ship refrigerated or frozen monohydrate Does not include a fasting specimen Ship refrigerated or frozen G009 GLUCOSE TOLERANCE TEST (GTT), PREGNANCY, 75g GLUCOSE B195 GLUCOSE CHALLENGE TEST (GCT), PREGNANCY, 75G GLUCOSE G010 GLUCOSE TOLERANCE TEST, ORAL (OGTT) Test modifications (test details) Specimen 2 ml (1 ml min) plasma from 1 Grey Top (Sodium Fluoride) tube for each timed specimen Draw baseline fasting specimen Dissolve 75g Glucose in 300 ml water Administer orally over a period of 5 minutes Draw additional specimens at 10 & 20 hours Note time drawn on each container label and test request form Overnight fasting mandatory Ship refrigerated or frozen Test modifications (test details) Specimen 2 ml (1 ml min) plasma from 1 Grey Top (Sodium Fluoride) tube drawn 2 hours after oral administration of 75 g glucose Overnight fasting is NOT mandatory Ship refrigerated or frozen Test modifications (test details) Specimen 2 ml (1 ml min) plasma from 1 Grey Top (Sodium Fluoride) tube each for Fasting and Post glucose specimens Collect fasting specimen Dissolve 75g Glucose in adults / 175 g / Kg body weight in children (not exceeding 75g) in 300mL water Administer orally over a period of 5 minutes Collect post glucose sample exactly after 2 hours Overnight fasting is mandatory Ship refrigerated or frozen Urine Specimens NOT REQUIRED 2 ml (1 ml min) plasma from 1 Grey Top (Sodium Fluoride) tube for each timed specimen Draw baseline fasting specimen Dissolve 825g glucose monohydrate in 300 ml water Administer orally over a period of 5 minutes Draw additional specimens at 10 & 20 hours Note time drawn on each container label and test request form Overnight fasting mandatory Ship refrigerated or frozen 2 ml (1 ml min) plasma from 1 Grey Top (Sodium Fluoride) tube drawn 2 hours after oral administration of 825 g glucose monohydrate Overnight fasting is NOT mandatory Ship refrigerated or frozen 2 ml (1 ml min) plasma from 1 Grey Top (Sodium Fluoride) tube each for Fasting and Post glucose specimens Collect fasting specimen Dissolve 825g Glucose monohydrate in adults / 192 g / Kg body weight in children (not exceeding 825g) in 300mL water Administer orally over a period of 5 minutes Collect post glucose sample exactly after 2 hours Overnight fasting is mandatory Ship refrigerated or frozen Urine Specimens NOT REQUIRED C021 LEAD, 24 HOUR URINE Test modifications (test details) Method Atomic Absorption Spectrometry with ICPMS AAS Zeeman correction R096 VITAMIN A (RETINOL) Test modifications (test details) Price Rs 6,00000 Rs 4,00000 HPLC R117 VITAMIN E; Test modifications (test details) Price Rs 6,00000 Rs 4,00000 HPLC TOCOPHEROL Z863 SCA (SPINOCEREBELLAR ATAXIA), Test modifications (test details) Price Rs 9,00000 Rs 11, Z863 SCA (SPINOCEREBELLAR ATAXIA), Test modifications (test details) Comments NA NA

9 Issue : 3; Rev 1 Rev Date : 1/7/ C022 LEAD, RANDOM URINE Test modifications (test details) Method Atomic Absorption Spectrometry with Zeeman correction B150 GAD 65 (GLUTAMIC Test modifications (test details) Sample by Sat 9 am: Same ACID DECARBOXYLASE 65), IgG R049 ALDOSTERONE, SERUM R072 PLASMA RENIN, Test modifications (test details) Sample by Fri 9 am; Same DIRECT B175 ALDOSTERONE / PLASMA RENIN DIRECT RATIO Z812 INFERTILITY PANEL, FEMALES B197 BILE ACIDS, TOTAL, SERUM J154 ELECTRON MICROSCOPY (TEM) Z830, KIDNEY BIOPSY PANEL OS107 BACTERIAL MENINGITIS CONFIRMATORY PANEL Z863 SCA (SPINOCEREBELLAR ATAXIA), s209 CHIKUNGUNIYA VIRUS ANTIBODY,IgM N097 CANCER 50 GENE PANEL, NGS N097 CANCER 50 GENE PANEL, NGS N097 CANCER 50 GENE PANEL, NGS N097 CANCER 50 GENE PANEL, NGS ICPMS Sample by Wed/Sat 9 am: Same Test modifications (test details) Sample by Fri 9 am; Same Sample by Tue/Fri 9 am; Same Sample by Tue/Fri 9 am; Same Test modifications (test details) Sample by Fri 9 am; Same Sample by Tue/Fri 9 am; Same AAS Test modifications (test details) Price Rs 3,30000 Rs 2,50000 Test modifications (test details) Sample by Mon/Wed/Fri 9 am; same Sample Mon through Sat by 4 pm; Same Test modifications (test details) Sample Daily by 6 pm; 7 Sample Daily by 6 pm; 10 Test modifications (test details) Sample Daily by 6 pm; 7 Sample Daily by 6 pm; 10 Test modifications (test details) Specimen 4 ml (2 ml min) Whole Blood in 1 Lavender top (EDTA) tube OR 1 ml CSF OR Throat swab Ship refrigerated DO NOT FREEZE 2 ml (1 ml min) CSF OR Throat swab Ship refrigerated DO NOT FREEZE HISTOLOGY HISTOLOGY Test modifications (test details) Comments NA NA Test modifications (test details) Price Rs Rs MICROBIOLOGY Test modifications (test details) Specimen Submit formalin fixed paraffin embedded tissue block Ship at room temperature Block should have at least 10% tumor tissue Submit 3 ml (2 ml min) Whole Blood in 1 Lavender top (EDTA) tube Ship refrigerated within 72 hrs OR formalin fixed paraffin embedded tissue block Ship at room temperature Block should have at least 10% tumor tissue Test modifications (test details) Refrigerator NA 72 HRS Test modifications (test details) Comments Submit Whole Blood for Leukemias and Tissue block for solid tumors Test modifications (test details) Components ABL1, EGFR, GNAS, KRAS, PTPN11, AKT1, ERBB2, GNAQ, MET, RB1, ALK, ERBB4, HNF1A, MLH1, RET, APC, EZH2, HRAS, MPL, SMAD4, ATM, FBXW7, IDH1, NOTCH1, SMARCB1, BRAF, FGFR1, JAK2, NPM1, SMO, CDH1, FGFR2, JAK3, NRAS, SRC, CDKN2A, FGFR3, IDH2, PDGFRA,

10 Issue : 3; Rev 1 Rev Date : 1/7/ H180 PROTEIN S, FUNCTIONAL N097 CANCER 50 GENE PANEL, NGS N072 EGFR, MUTATIONAL ANALYSIS OS142 GLUTATHIONE S TRAN SFERASE MUTATION L005 AB (CLASS 1) TYPING L006 DR (CLASS II) TYPING N023 DNA TYPING FOR KIDNEY / LIVER TRANSPLANT, PCR L018 DR & DQB1 (CLASS II) TYPING N106 DNA ANALYSIS FOR PATERNITY TESTING Z860 PRE TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL Z873 PRE TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL 3 Unblock STK11, CSF1R, FLT3, KDR, PIK3CA, TP53, CTNNB1, GNA11, KIT, PTEN, VHL Test modifications (test details) Sample by 1st / 15th of every month; on 15th / 30th of every month Sample by Mon 11 am; 10 Test modifications (test details) Sample by Tue 11 am; Mon Sample by Mon/ Thu 9 am; Fri/ Tue Unblock Unblock Unblock Unblock Unblock Unblock Unblock Z855 PRE TRANSPLANT WORKUP NON SENSITIZED RECIPIENT PANEL 1 Unblock Z857 PRE TRANSPLANT WORKUP PANEL Z858 PRE TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL 4 Unblock Unblock S231 FECAL CALPROTECTIN Test modifications (test details) Method Enzyme Immunoassay CLIA OS100 ACTN3 (SPORTS GENE), GENOTYPING Test modifications (test details) Price Rs 4,50000 Rs 4, OS100 ACTN3 (SPORTS GENE), GENOTYPING Test modifications (test details) Sample by Thu 11 am; 10 Sample by Mon 11 am; OS102 ADRB2 GENOTYPING FOR BETA 2 AGONIST RESPONSIVENESS Test modifications (test details) Price Rs 4,25000 Rs 4, OS102 ADRB2 GENOTYPING FOR BETA 2 AGONIST RESPONSIVENESS Test modifications (test details) Sample by Sat 11 am; 10 Sample by Sat 11 am; OS103 ALPHA THALASSEMIA Test modifications (test details) Price Rs 3,80000 Rs 4,20000

11 Issue : 3; Rev 1 Rev Date : 1/7/ OS103 ALPHA THALASSEMIA Test modifications (test details) Sample by Tue 11 am ; 9 Sample by Sat 11 am ; OS199 WARFARIN SENSITIVITY Test modifications (test details) Price Rs 14,00000 Rs 14, OS199 WARFARIN SENSITIVITY Test modifications (test details) Sample by Sat 11 am; 8 Sample Daily by 11 am; OS175 PAN FUNGAL AND Test modifications (test details) Price Rs 16,00000 Rs 15,60000 IDENTIFICTION, PCR OS175 PAN FUNGAL AND Test modifications (test details) Sample by Thu 11 am; 8 Sample by Tue/Sat 11 am; Mon/Thu IDENTIFICTION, PCR OS109 B CELL REARRANGEMENT Test modifications (test details) Price Rs 20,00000 Rs 19, OS109 B CELL REARRANGEMENT Test modifications (test details) Sample by Sat 11 am; 10 Sample by Sat 11 am; OS127 CYSTIC FIBROSIS Test modifications (test details) Price Rs 16,50000 Rs 9, OS127 CYSTIC FIBROSIS Test modifications (test details) Sample Daily by 11 am; 13 Sample Daily by 11 am; 6 weeks OS130 DPD Gene Mutations (5 FU toxicity) detection Test modifications (test details) Price Rs 16,00000 Rs 8, OS130 DPD Gene Mutations (5 FU toxicity) detection Test modifications (test details) Sample by Sat 9 am; 10 Sample Daily by 11 am; OS147 HEMOGLOBIN D PUNJAB MUTATION Test modifications (test details) Price Rs 4,70000 Rs 4,56000 ANALYSIS OS147 HEMOGLOBIN D PUNJAB MUTATION Test modifications (test details) Sample by Tue/ Thu 9 am; 8 Sample by Mon / Wed 11 am; 10 ANALYSIS OS137 FRAGILE X (FMR1) MUTATION SCREEN Test modifications (test details) Price Rs 8,60000 Rs 8, OS137 FRAGILE X (FMR1) MUTATION SCREEN Test modifications (test details) Sample by Tue 11 am; 10 Sample by Sat 11 am; OS156 JC/BK VIRUS, PCR Test modifications (test details) Price Rs 6,50000 Rs 6, OS156 JC/BK VIRUS, PCR Test modifications (test details) Sample by Wed/Sat 11 am; 6 Sample Daily by 11 am; OS115 CEBPA MUTATION Test modifications (test details) Price Rs 7,50000 Rs 7, OS115 CEBPA MUTATION Test modifications (test details) Sample by Wed 11 am; 8 Sample Daily by 11 am; OS118 C KIT MUTATION, PCR Test modifications (test details) Price Rs 5,00000 Rs 5, OS118 C KIT MUTATION, PCR Test modifications (test details) Sample by Wed 11 am; 9 Sample by Wed / Sat 11 am; OS108 BACTERIAL PNEUMONIA PANEL, Test modifications (test details) Price Rs 7,10000 Rs 6,96000 PCR OS108 BACTERIAL Test modifications (test details) Sample Daily ; 7 Sample Mon / Wed / Fri 11 am ;

12 Issue : 3; Rev 1 Rev Date : 1/7/2018 PNEUMONIA PANEL, 4 PCR OS196 TYPHOID DNA Test modifications (test details) Price Rs 6,25000 Rs 6, OS196 TYPHOID DNA Test modifications (test details) Sample Daily by 11 AM; REPORT 8 DAYS Sample Daily by 11 am; OS105 ANGELMAN SYNDROME Test modifications (test details) Price Rs 6,80000 Rs 7, OS105 ANGELMAN SYNDROME Test modifications (test details) Sample by Sat 11 am; 10 Sample by Sat 11 am; OS114 CANDIDA ALBICANS, PCR Test modifications (test details) Price Rs 10,00000 Rs 6, OS114 CANDIDA ALBICANS, PCR Test modifications (test details) Sample by Thu 11 am; 9 Sample Daily by 11 am; OS119 CLOSTRIDIUM DIFFICILE, Test modifications (test details) Price Rs 3,70000 Rs 3,96000 PCR OS119 CLOSTRIDIUM DIFFICILE, Test modifications (test details) Sample by Wed / Sat 11 pm; Mon / Tue Sample by Tue / Sat 11 am; Mon / Thu PCR OS144 HAPTOGLOBIN GENOTYPING Test modifications (test details) Price Rs 4,60000 Rs 4, OS144 HAPTOGLOBIN GENOTYPING Test modifications (test details) Sample by Wed/Sat 11 am; 6 Sample by Tue / Sat 11 am; OS145 HEPATITIS A VIRUS RNA, PCR Test modifications (test details) Price Rs 5,00000 Rs 5, OS145 HEPATITIS A VIRUS RNA, PCR Test modifications (test details) Sample by Fri 11 am; Wed Sample Daily by 11 am; OS169 MMC (MATERNAL MYOPATHY WITH Test modifications (test details) Price Rs 7,50000 Rs 8,40000 CARDIOMYOPATHY), OS169 MMC (MATERNAL MYOPATHY WITH Test modifications (test details) Sample Daily by 11 am ; 10 Sample Daily by 11 am ; 10 CARDIOMYOPATHY), OS197 UGT1A1 GENE POLYMORPHISM Test modifications (test details) Price Rs 7,50000 Rs 7,20000 (NUCLEOTIDE 'TA' REPEATS) OS197 UGT1A1 GENE POLYMORPHISM Test modifications (test details) Sample Daily by 11 am; 14 Sample Wed / Sat by 11 am; 10 (NUCLEOTIDE 'TA' REPEATS) OS124 CRYTOCOCCUS NEOFORMANS Test modifications (test details) Price Rs 9,50000 Rs 9,48000, PCR OS124 CRYTOCOCCUS NEOFORMANS Test modifications (test details) Sample Daily by 11 am; 18 Sample Daily by 11 am; 13, PCR OS162 MELAS (MITOCHONDRIAL ENCEPHALOPATHY & LACTIC ACIDOSIS WITH STROKE LIKE Test modifications (test details) Price Rs 6,80000 Rs 7,20000

13 Issue : 3; Rev 1 Rev Date : 1/7/2018 SYNDROME), OS162 MELAS (MITOCHONDRIAL ENCEPHALOPATHY & LACTIC ACIDOSIS WITH STROKE LIKE SYNDROME), OS163 MERRF (MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED RED FIBRES), MUTATION Test modifications (test details) Sample Daily by 11 am; 10 Sample Daily by 11 am; 10 Test modifications (test details) Price Rs 10,00000 Rs 12, OS163 MERRF (MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED RED FIBRES), MUTATION Test modifications (test details) Sample Daily by 11 am; 10 Sample Daily by 11 am; OS135 FIP1L1 PGDFRA GENE REARRANGEMENT OS135 FIP1L1 PGDFRA GENE REARRANGEMENT OS138 FREIDREICHS ATAXIA MUTATION ANALYSIS OS138 FREIDREICHS ATAXIA MUTATION ANALYSIS OS195 TOXOPLASMA DNA, PCR OS195 TOXOPLASMA DNA, PCR OS193 T CELL GENE REARRANGEMENT OS193 T CELL GENE REARRANGEMENT OS139 G6PD GENE MUTATION OS139 G6PD GENE MUTATION OS168 MITOCHONDRIAL PANEL Test modifications (test details) Price Rs 7,60000 Rs 7,80000 Test modifications (test details) Sample by Tue 11 am; 10 Sample by Mon 11 am; 12 Test modifications (test details) Price Rs 7,60000 Rs 6,60000 Test modifications (test details) Sample by Tue 11 am; 10 Sample by Mon / Fri 11 am; 10 Test modifications (test details) Price Rs 3,60000 Rs 3,60000 Test modifications (test details) Sample Daily by 11 am; 8 Sample Tue / Sat by 11 am; Sat / Wed Test modifications (test details) Price Rs 20,00000 Rs 16,80000 Test modifications (test details) Sample by Sat 11 am; 9 Sample Daily by 11 am; 13 Test modifications (test details) Price Rs 5,20000 Rs 5,04000 Test modifications (test details) Sample by Tue 11 am; 8 Sample by Mon 11 am; 10 Test modifications (test details) Price Rs 41,20000 Rs 42, OS168 MITOCHONDRIAL PANEL Test modifications (test details) Sample Daily by 11 am ; 10 Sample Daily by 11 am ; 10

14 Issue : 3; Rev 1 Rev Date : 1/7/ OS150 HEPATITIS G VIRUS RNA, PCR Test modifications (test details) Price Rs 6,10000 Rs 5, OS150 HEPATITIS G VIRUS RNA, PCR Test modifications (test details) Sample by Thu 11 am; Wed Sample Daily by 11 am; OS154 IgVH GENE MUTATION Test modifications (test details) Price Rs 11,00000 Rs 10, OS154 IgVH GENE MUTATION Test modifications (test details) Sample by Wed 11 am; 8 Sample by Tue 11 am; OS165 MICM (MATERNALLY INHERITED Test modifications (test details) Price Rs 7,50000 Rs 8,40000 CARDIOMYOPATHY), OS165 MICM (MATERNALLY INHERITED Test modifications (test details) Sample Daily by 11 am ; 10 Sample Daily by 11 am ; 10 CARDIOMYOPATHY), OS170 MM (MITOCHONDRIAL MYOPATHY), Test modifications (test details) Price Rs 9,50000 Rs 10, OS170 MM (MITOCHONDRIAL MYOPATHY), Test modifications (test details) Sample Daily by 11 am ; 10 Sample Daily by 11 am ; OS141 GANCICLOVIR RESISTANCE Test modifications (test details) Price Rs 5,70000 Rs 7, OS141 GANCICLOVIR RESISTANCE Test modifications (test details) Sample by Tue 11 am; 9 Sample by Mon 11 am; OS123 CONNEXIN 30 Test modifications (test details) Price Rs 5,00000 Rs 5, OS123 CONNEXIN 30 Test modifications (test details) Sample by Wed 11 am; 9 Sample by Sat 11 am; OS122 CONNEXIN 26 Test modifications (test details) Price Rs 6,80000 Rs 7, OS122 CONNEXIN 26 Test modifications (test details) Sample by Wed 11 am; 9 Sample by Sat 11 am; OS158 KRAS CODON 61 Test modifications (test details) Price Rs 6,80000 Rs 6, OS158 KRAS CODON 61 Test modifications (test details) Sample by Mon 11 am; 10 Sample by Sat 11 am; OS121 COMT GENOTYPING Test modifications (test details) Price Rs 31,00000 Rs 36, OS121 COMT GENOTYPING Test modifications (test details) Sample by Mon 11 am ; 8 Sample by Sat 11 am ; OS104 ALPHA THALASSEMIA, PRENATAL Test modifications (test details) Price Rs 11,00000 Rs 10, OS104 ALPHA THALASSEMIA Test modifications (test details) Sample by Thu 11 am; 9 Sample by Mon 11 am; 11, PRENATAL OS201 WT 1 MUTATION Test modifications (test details) Price Rs 7,25000 Rs 9, OS201 WT 1 MUTATION Test modifications (test details) Sample by Wed 9 am report after 8 Sample Daily by 11 am; 18

15 Issue : 3; Rev 1 Rev Date : 1/7/ OS107 BACTERIAL MENINGITIS CONFIRMATORY PANEL OS107 BACTERIAL MENINGITIS CONFIRMATORY PANEL OS143 HEMOCHROMATOSIS 2 Test modifications (test details) Price Rs 4,70000 Rs 5,16000 Test modifications (test details) Sample by Wed / Sat 11 am; Sat / Wed Sample by Tue / Sat 11 am; Sat / Tue Test modifications (test details) Price Rs 7,50000 Rs 7, OS143 HEMOCHROMATOSIS 2 Test modifications (test details) Sample Daily by 9 am; 32 Sample Daily by 11 am; OS151 HIV 2, PCR Test modifications (test details) Price Rs 6,80000 Rs 4, OS151 HIV 2, PCR Test modifications (test details) Sample by Mon 11 am; Fri Sample Daily by 11 am; OS140 GALACTOSEMIA (GALT) Test modifications (test details) Price Rs 10,00000 Rs 8,28000 GENE MUTATION OS140 GALACTOSEMIA (GALT) GENE MUTATION OS166 MITOCHONDRIAL PANEL OS166 MITOCHONDRIAL PANEL 1 Test modifications (test details) Sample by Tue 11am; 11 Sample Daily by 11am; 15 Test modifications (test details) Price Rs 23,70000 Rs 24,00000 Test modifications (test details) Sample Daily by 11 am ; 10 Sample Daily by 11 am ; OS160 MALARIA, PCR Test modifications (test details) Price Rs 3,10000 Rs 3, OS160 MALARIA, PCR Test modifications (test details) Sample by Tue / Sat 11 am; Sat/Wed Sample Daily by 11 am; OS181 RUBELLA, PCR Test modifications (test details) Price Rs 3,75000 Rs 3, OS181 RUBELLA, PCR Test modifications (test details) Sample by Wed/Sat 11 am; Sat/Tue Sample Daily by 11 am; OS178 PLASMINOGEN ACTIVATOR Test modifications (test details) Price Rs 13,00000 Rs 14,40000 INHIBITOR 1/SERPINE 1, 4G/5G GENOTYPING OS178 PLASMINOGEN ACTIVATOR INHIBITOR 1/SERPINE 1, 4G/5G GENOTYPING Test modifications (test details) Sample by Wed 11 am; 8 Sample by Tue 11 am; OS167 MITOCHONDRIAL PANEL OS167 MITOCHONDRIAL PANEL OS174 PAN FUNGAL, PCR Test modifications (test details) Price Rs 23,70000 Rs 24,00000 Test modifications (test details) Sample Daily by 11 am ; 10 Sample Daily by 11 am ; 10 Test modifications (test details) Price Rs 4,30000 Rs 4,20000

16 Issue : 3; Rev 1 Rev Date : 1/7/ OS174 PAN FUNGAL, PCR Test modifications (test details) Sample by Thu 11 am; 8 Sample by Tue / Sat 11 am; Mon / Thu OS146 HEMOGLOBIN D IRAN MUTATION ANALYSIS Test modifications (test details) Price Rs 4,70000 Rs 4, OS146 HEMOGLOBIN D IRAN MUTATION ANALYSIS Test modifications (test details) Sample by Tue/ Thu 9 am; 8 Sample by Mon / Wed 11 am; OS148 HEMOGLOBIN E (GLU 26LYS) MUTATION Test modifications (test details) Price Rs 4,70000 Rs 4,56000 ANALYSIS OS148 HEMOGLOBIN E (GLU 26LYS) MUTATION Test modifications (test details) Sample by Tue/ Thu 9 am; 8 Sample by Mon / Wed 11 am; 10 ANALYSIS OS149 HEPATITIS D VIRUS, PCR Test modifications (test details) Price Rs 6,50000 Rs 6, OS149 HEPATITIS D VIRUS, PCR Test modifications (test details) Sample by Thu 11 am; Wed Sample Daily by 11 am; OS159 LEPTOSPIRA, PCR Test modifications (test details) Price Rs 2,50000 Rs 2, OS159 LEPTOSPIRA, PCR Test modifications (test details) Sample by Mon / Thu 11 am; Wed / Sat Sample by Wed / Sat 11 am; Mon / Thu OS161 MEDULLARY THYROID CARCINOMA, Test modifications (test details) Price Rs 14,00000 Rs 15, OS161 MEDULLARY THYROID CARCINOMA, Test modifications (test details) Sample Daily by 11 am; 10 Sample Daily by 11 am; OS164 METHYLGUANINE METHYLTRANSFERASE Test modifications (test details) Price Rs 7,80000 Rs 8,40000 (MGMT) OS164 METHYLGUANINE METHYLTRANSFERASE Test modifications (test details) Sample Daily by 11 am; 22 Sample Mon by 11 am; 13 (MGMT) OS194 TORCH DNA Test modifications (test details) Price Rs 8,10000 Rs 7, OS194 TORCH DNA Test modifications (test details) Sample by Wed/Sat 11 am; Fri/Tue Sample Daily by 11 am; OS179 PRADER WILLI SYNDROME MUTATION, METHYLATION SPECIFIC PCR Test modifications (test details) Price Rs 8,10000 Rs 8, OS179 PRADER WILLI SYNDROME MUTATION, METHYLATION SPECIFIC PCR Test modifications (test details) Sample by Sat 11 am; 11 Sample by Sat 11 am; OS180 RETT SYNDROME Test modifications (test details) Price Rs 6,25000 Rs 6, OS180 RETT SYNDROME Test modifications (test details) Sample by Mon 11 am; 11 Sample by Sat 11 am; OS187 SICKLE CELL Test modifications (test details) Price Rs 3,75000 Rs 3, OS187 SICKLE CELL Test modifications (test details) Sample by Tue 11 am; 10 Sample by Mon / Wed 11 am;

17 Issue : 3; Rev 1 Rev Date : 1/7/ OS202 Y CHROMOSOME MICRODELETION, PCR OS202 Y CHROMOSOME MICRODELETION, PCR OS132 DRPLA GENE ANALYSIS OS132 DRPLA GENE ANALYSIS 10 Test modifications (test details) Price Rs 10,00000 Rs 8,16000 Test modifications (test details) Sample by Wed 9 am report after 9 Sample by Wed / Sat 11 am; 10 Test modifications (test details) Price Rs 7,00000 Rs 6,30000 Test modifications (test details) Sample by Tue 11 am; 10 Sample by Mon 11 am; OS125 CYP2C19 GENOTYPING Test modifications (test details) Price Rs 8,25000 Rs 7, OS125 CYP2C19 GENOTYPING Test modifications (test details) Sample by Wed 11 am; 11 Sample by Sat 11 am; OS126 CYP3A4*22 Test modifications (test details) Price Rs 6,60000 Rs 6,36000 GENOTYPING OS126 CYP3A4*22 Test modifications (test details) Sample by Sat 11 am; 10 Sample by Sat 11 am; 10 GENOTYPING S063 HIV 1 & 2 ANTIBODIES, Test modifications (test details) Specimen 2 ml (1 ml min) serum from 1 SST 2 ml (1 ml min) serum from 1 SST MICROBIOLOGY WESTERN BLOT Ship refrigerated or frozen Ship refrigerated or frozen Only primary sample tube is accepted Aliquoted samples not accepted S063 HIV 1 & 2 ANTIBODIES, WESTERN BLOT N131 CHIKUNGUNYA VIRUS, PCR QUALITATIVE Test modifications (test details) PreTestInfo No special preparation required No special preparation required Test modifications (test details) Specimen 3 ml (2 ml min) Whole Blood / Plasma in 1 Lavender Top (EDTA) Tube OR 2 ml (1 ml min) Serum from 1 SST OR 2 ml (1 ml min) CSF in a sterile screw capped container Ship refrigerated DO NOT FREEZE Only primary sample tube is accepted Aliquoted samples not accepted 3 ml (2 ml min) Whole Blood OR 2 ml (1 ml min) CSF in a sterile screw capped container Ship refrigerated DO NOT FREEZE MICROBIOLOGY N131 CHIKUNGUNYA VIRUS, PCR QUALITATIVE N131 CHIKUNGUNYA VIRUS, PCR QUALITATIVE N131 CHIKUNGUNYA VIRUS, PCR QUALITATIVE E018 OLIGOCLONAL BANDS IgG, CSF & SERUM E018 OLIGOCLONAL BANDS IgG, CSF & SERUM E018 OLIGOCLONAL BANDS IgG, CSF & SERUM E018 OLIGOCLONAL BANDS IgG, CSF & SERUM Test modifications (test details) Room 4 hrs 4 hrs Test modifications (test details) Refrigerator 72 hrs 72 hrs Test modifications (test details) Frozen NA NA Test modifications (test details) Test Name CSF & SERUM PROTEIN ELECTROPHORESIS / OLIGOCLONAL BANDS OLIGOCLONAL BANDS IgG, CSF & SERUM ELECTROPHORESIS Test modifications (test details) Method Agarose gel / Capillary Electrophoresis Isoelectrofocusing Immunoturbidimetry ELECTROPHORESIS Nephelometry Test modifications (test details) Price Rs 4,20000 Rs 5,00000 ELECTROPHORESIS Test modifications (test details) Comments Also see MULTIPLE SCLEROSIS PANELs; MYELIN ASSOCIATED Also see MULTIPLE SCLEROSIS PANELs; MYELIN ASSOCIATED ELECTROPHORESIS

18 Issue : 3; Rev 1 Rev Date : 1/7/ E018 OLIGOCLONAL BANDS IgG, CSF & SERUM GLYCOPROTEIN; MYELIN ASSOCIATED GLYCOPROTEIN SULFATED GLUCURONIC PARAGLOBOSIDE AUTOANTIBODY, IgM Test modifications (test details) Usage Oligoclonal bands are present in less than 85% of patients with clinically definite Multiple Sclerosis Ideally serum and CSF should be tested simultaneously to distinguish between production of oligoclonal bands due to peripheral gammopathy from that due to local production in the CNS Other conditions which show oligoclonal bands are Subacute sclerosing panencephalitis, Inflammatory polyneuropathy, CNS Lupus and Brain tumors GLYCOPROTEIN; MYELIN ASSOCIATED GLYCOPROTEIN SULFATED GLUCURONIC PARAGLOBOSIDE AUTOANTIBODY, IgM Isofocusing is the gold standard technique with greatest sensitivity & specificity for diagnosis of Multiple sclerosis Oligoclonal bands are present in 90% of patients with clinically definite Multiple Sclerosis Ideally serum and CSF should be tested simultaneously to distinguish between production of oligoclonal bands due to peripheral gammopathy from that due to local production in the CNS Other conditions which show oligoclonal bands are Subacute sclerosing panencephalitis, Inflammatory polyneuropathy, CNS Lupus and Brain tumors ELECTROPHORESIS E018 OLIGOCLONAL BANDS IgG, CSF & SERUM OS188 SICKLE CELL, PRENATAL OS188 SICKLE CELL, PRENATAL Test modifications (test details) Components CSF & SERUM ISOELECTROFOCUSING, CSF & SERUM IgG LEVELS Test modifications (test details) Specimen 4 ml (2 ml min) Whole Blood in 1 Lavender top (EDTA) Tube from both parents AND 10 ml (5 ml min) Amniotic fluid in a sterile screw capped container Ship refrigerated DO NOT FREEZE It is mandatory to send a Signed Prenatal Consent Form with the specimen 3 ml (2 ml min) Whole Blood in 1 Lavender top (EDTA) Tube from the mother AND 10 ml (5 ml min) Amniotic fluid in a sterile screw capped container Ship refrigerated DO NOT FREEZE It is mandatory to send a Signed Prenatal Consent Form with the specimen ELECTROPHORESIS Test modifications (test details) Price Rs 10,75000 Rs 7, OS188 SICKLE CELL, PRENATAL Test modifications (test details) Sample by Tue 11 am; 10 Sample by Mon/Wed 11 am; OS188 SICKLE CELL, PRENATAL H062 TYPHI DOT / SALMONELLA TYPHI IgM H062 TYPHI DOT / SALMONELLA TYPHI IgM Z181 MULTIPLE SCLEROSIS PANEL 1 Test modifications (test details) Comments Consent form is mandatory Test modifications (test details) Test Name Styphi IgM TYPHI DOT / SALMONELLA TYPHI IgM MICROBIOLOGY Test modifications (test details) Daily Daily MICROBIOLOGY Test modifications (test details) Method BCG, Nephelometry, Immunoturbidimetry, Agarose Gel BCG, Isoelectric focusing, Immunoturbidimetry, Nephelometry

19 Issue : 3; Rev 1 Rev Date : 1/7/ Z181 MULTIPLE SCLEROSIS PANEL Z181 MULTIPLE SCLEROSIS PANEL Z181 MULTIPLE SCLEROSIS PANEL Z181 MULTIPLE SCLEROSIS PANEL E004 OLIGOCLONAL BANDS, CSF PROTEIN ELECTROPHORESIS Z182 MULTIPLE SCLEROSIS PANEL Z182 MULTIPLE SCLEROSIS PANEL Z182 MULTIPLE SCLEROSIS PANEL 2 Electrophoresis Test modifications (test details) Price Rs 5,75000 Rs 6,50000 Test modifications (test details) Sample Daily by 9 am; Next Test modifications (test details) Comments Strictly adhere to specimen volumes for CSF Test modifications (test details) Components *IgG Synthesis Index & Rate *Oligoclonal Bands, CSF Test modifications (test details) Test Name CSF PROTEIN ELECTROPHORESIS / OLIGOCLONAL BANDS Test modifications (test details) Method BCG, Nephelometry, Immunoturbidimetry, Agarose Gel Electrophoresis, RIA Sample Daily by 9 am; Next *IgG Synthesis Index & Rate *Oligoclonal Bands, CSF & Serum OLIGOCLONAL BANDS, CSF PROTEIN ELECTROPHORESIS BCG, Nephelometry, Immunoturbidimetry, Isoelectric Focusing, RIA Test modifications (test details) Price Rs 11,00000 Rs 11,75000 Test modifications (test details) Components *IgG Synthesis Index & Rate *Oligoclonal Bands, CSF *Myelin Basic Protein, CSF (Code RW135) *IgG Synthesis Index & Rate *Oligoclonal Bands, CSF & Serum *Myelin Basic Protein, CSF (Code RW135) H018 G 6 PD, QUANTITATIVE Test modifications (test details) Method Spectrophotometry Kinetic UV Z365 HEPATITIS A & B VIRUS ELISA EVALUATION Z136 HEPATITIS B INFANT ELISA FOLLOW UP PANEL Z373 HEPATITIS ATYPICAL ELISA VIRUS CONFIRMATION Z133 HEPATITIS ACUTE ELISA DIAGNOSTIC PANEL Z132 HEPATITIS A ELISA DIAGNOSTIC PANEL Z134 HEPATITIS B CHRONIC ELISA PANEL Z138 HEPATITIS, VIRAL, ELISA PANEL Z371 HEPATITIS ACUTE ELISA VIRUS SCREEN Z372 HEPATITIS ACUTE ELISA VIRUS CONFIRMATION S209 CHIKUNGUNIYA VIRUS Test modifications (test details) Specimen 2 ml (1 ml min) serum from 1 SST MICROBIOLOGY ANTIBODY,IgM Ship refrigerated or frozen S209 CHIKUNGUNIYA VIRUS Test modifications (test details) Room 24 HRS MICROBIOLOGY ANTIBODY,IgM S209 CHIKUNGUNIYA VIRUS Test modifications (test details) Refrigerator 5 DAYS MICROBIOLOGY ANTIBODY,IgM S209 CHIKUNGUNIYA VIRUS Test modifications (test details) Frozen 2 WEEKS MICROBIOLOGY ANTIBODY,IgM S209 CHIKUNGUNIYA VIRUS Test modifications (test details) Method Immunochromatography MICROBIOLOGY ANTIBODY,IgM S209 CHIKUNGUNIYA VIRUS Test modifications (test details) Daily MICROBIOLOGY ANTIBODY,IgM S209 CHIKUNGUNIYA VIRUS ANTIBODY,IgM Test modifications (test details) Comments MICROBIOLOGY

The Center for PERSONALIZED DIAGNOSTICS

The Center for PERSONALIZED DIAGNOSTICS The Center for PERSONALIZED DIAGNOSTICS Precision Diagnostics for Personalized Medicine A joint initiative between The Department of Pathology and Laboratory Medicine & The Abramson Cancer Center The (CPD)

More information

Genomic Medicine: What every pathologist needs to know

Genomic Medicine: What every pathologist needs to know Genomic Medicine: What every pathologist needs to know Stephen P. Ethier, Ph.D. Professor, Department of Pathology and Laboratory Medicine, MUSC Director, MUSC Center for Genomic Medicine Genomics and

More information

Predictive biomarker profiling of > 1,900 sarcomas: Identification of potential novel treatment modalities

Predictive biomarker profiling of > 1,900 sarcomas: Identification of potential novel treatment modalities Predictive biomarker profiling of > 1,900 sarcomas: Identification of potential novel treatment modalities Sujana Movva 1, Wenhsiang Wen 2, Wangjuh Chen 2, Sherri Z. Millis 2, Margaret von Mehren 1, Zoran

More information

Acetylcholine Receptor Binding Antibody

Acetylcholine Receptor Binding Antibody Acetylcholine Receptor Binding Antibody Order Name: ACETY BND Test Number: 5500010 REV DATE:9/17/2008 Acetylcholine Receptor Binding Antibody RIA Preferred 1 ml (0.5) Serum Clot Activator (Red Top, No-Gel)

More information

IntelliGENSM. Integrated Oncology is making next generation sequencing faster and more accessible to the oncology community.

IntelliGENSM. Integrated Oncology is making next generation sequencing faster and more accessible to the oncology community. IntelliGENSM Integrated Oncology is making next generation sequencing faster and more accessible to the oncology community. NGS TRANSFORMS GENOMIC TESTING Background Cancers may emerge as a result of somatically

More information

Accel-Amplicon Panels

Accel-Amplicon Panels Accel-Amplicon Panels Amplicon sequencing has emerged as a reliable, cost-effective method for ultra-deep targeted sequencing. This highly adaptable approach is especially applicable for in-depth interrogation

More information

Fluxion Biosciences and Swift Biosciences Somatic variant detection from liquid biopsy samples using targeted NGS

Fluxion Biosciences and Swift Biosciences Somatic variant detection from liquid biopsy samples using targeted NGS APPLICATION NOTE Fluxion Biosciences and Swift Biosciences OVERVIEW This application note describes a robust method for detecting somatic mutations from liquid biopsy samples by combining circulating tumor

More information

Dr David Guttery Senior PDRA Dept. of Cancer Studies and CRUK Leicester Centre University of Leicester

Dr David Guttery Senior PDRA Dept. of Cancer Studies and CRUK Leicester Centre University of Leicester Dr David Guttery Senior PDRA Dept. of Cancer Studies and CRUK Leicester Centre University of Leicester dsg6@le.ac.uk CFDNA/CTDNA Circulating-free AS A LIQUID DNA BIOPSY (cfdna) Tumour Biopsy Liquid Biopsy

More information

Alkaline Phosphatase, Bone Specific

Alkaline Phosphatase, Bone Specific Alkaline Phosphatase, Bone Specific Order Name: ALK P BONE Test Number: 3656500 REV DATE:11/5/2010 Alkaline Phosphatase, Bone Specific IMMENZ Preferred 1 ml (0.3) Serum Clot Activator SST (Red/Gray or

More information

Aerobic Wound Culture and Stain

Aerobic Wound Culture and Stain Aerobic Wound Culture and Stain Order Name: C WOUN RTS Test Number: 6000153 Revision Date: 03/27/2014 Aerobic Wound Culture and Stain Culture Preferred 1 ml Tissue Sterile Screwtop Container Room Temperature

More information

CMS will not implement the new tier codes for Medicare/Medicaid claims for calendar year 2012.

CMS will not implement the new tier codes for Medicare/Medicaid claims for calendar year 2012. January 1, 2012 Re: 2012 AMA CPT Code Changes Dear Valued Client: The American Medical Association (AMA) has made Current Procedural Terminology (CPT) code changes to the 2012 edition of the CPT coding

More information

Targeted Agent and Profiling Utilization Registry (TAPUR ) Study. February 2018

Targeted Agent and Profiling Utilization Registry (TAPUR ) Study. February 2018 Targeted Agent and Profiling Utilization Registry (TAPUR ) Study February 2018 Precision Medicine Therapies designed to target the molecular alteration that aids cancer development 30 TARGET gene alterations

More information

July Monthly Update, Quest Diagnostics Nichols Institute, Valencia

July Monthly Update, Quest Diagnostics Nichols Institute, Valencia NEW TESTS Please Note: Not all test codes assigned to each assay are listed in the table of contents. Please refer to the complete listing on the page numbers indicated. Test Name Effective Date Page #

More information

Anti-FceR (CU Index) Antibody

Anti-FceR (CU Index) Antibody Anti-FceR (CU Index) Antibody Order Name: ANTI-FCER Test Number: 5587500 REV DATE:5/31/2007 Anti-FceR (CU Index) Antibody CU Index Preferred 2 ml (1mL) Serum Clot Activator SST (Red/Gray or Tiger Top)

More information

Date of Birth Gender Ethnicity/Family History Male Female Unknown. (Institutional Billing only. We DO NOT bill patients directly.)

Date of Birth Gender Ethnicity/Family History Male Female Unknown. (Institutional Billing only. We DO NOT bill patients directly.) PATIENT INFORMATION Last Name First M.I. CLINICAL LABORATORY Date of Birth Gender Ethnicity/Family History Male Female Unknown Molecular Diagnotics Patient or Sample ID# Institutional Account # (415) 514-8488

More information

LIST OF INVESTIGATIONS

LIST OF INVESTIGATIONS Karyotyping: K001 K002 LIST OF INVESTIGATIONS SAMPLE CONTAINER TYPE cells For Karyotyping [Single] cells For Karyotyping [Couple] Vacutainer Vacutainer 7-8 7-8 K003 Fetal Blood Sample For Karyotyping Vacutainer

More information

Detecting Oncogenic Mutations in Whole Blood

Detecting Oncogenic Mutations in Whole Blood WHITE PAPER Detecting Oncogenic Mutations in Whole Blood Analytical validation of Cynvenio Biosystems LiquidBiopsy circulating tumor cell (CTC) capture and next-generation sequencing (NGS) September 2013

More information

TECHNICAL NOTICE. The CPT coding in this notice is effective January 1, 2013 and replaces the coding currently in use for these assays

TECHNICAL NOTICE. The CPT coding in this notice is effective January 1, 2013 and replaces the coding currently in use for these assays TECHNICAL NOTICE The CPT coding in this notice is effective January 1, 2013 and replaces the coding currently in use for these assays December 2012 The notation (MAAA) indicates "Multianalyte Assay with

More information

April Monthly Update, Quest Diagnostics Nichols Institute, Valencia

April Monthly Update, Quest Diagnostics Nichols Institute, Valencia Revision Message! Please note: 4/20/15 communication revision for test code 17306- Vitamin D, 25-Hydroxy, Total, Immunoassay, New York patient message NEW TESTS Please Note: Not all test codes assigned

More information

Are there still any valid indications for thrombophilia screening in DVT?

Are there still any valid indications for thrombophilia screening in DVT? Carotid artery stenosis and risk of stroke Are there still any valid indications for thrombophilia screening in DVT? Armando Mansilha MD, PhD, FEBVS Faculty of Medicine of University of Porto Munich, 2016

More information

March Monthly Update, Quest Diagnostics Nichols Institute, Valencia

March Monthly Update, Quest Diagnostics Nichols Institute, Valencia NEW TESTS Please Note: Not all test codes assigned to each assay are listed in the table of contents. Please refer to the complete listing on the page numbers indicated. Test Code Test Name Effective Date

More information

Out-Patient Billing CPT Codes

Out-Patient Billing CPT Codes Out-Patient Billing CPT Codes Updated Date: August 3, 08 Client Billed Molecular Tests HPV DNA Tissue Testing 8764 No Medicare Billed - Molecular Tests NeoARRAY NeoARRAY SNP/Cytogenetic No 89 NeoLAB NeoLAB

More information

TEST REQUEST INFORMATION- VIROLOGY

TEST REQUEST INFORMATION- VIROLOGY Chlamydia/ Gonorrhea Nucleic Acid Amplification VC75 Qualitative Nucleic Acid Amplification SPECIMEN: Genital swab or first catch urine CONTAINER:GEN-PROBE APTIMA 2 Combo swab transport tube or urine transport

More information

EBUS-TBNA Diagnosis and Staging of Lung Cancer

EBUS-TBNA Diagnosis and Staging of Lung Cancer EBUS-TBNA Diagnosis and Staging of Lung Cancer Nirag Jhala MD, MIAC Professor of Pathology and Lab Med. Director of Anatomic Pathology and Cytopathology Lewis Katz School of Medicine@ Temple University

More information

October Courier Service on Holidays There will be no courier service Thursday, Dec. 24th, 2011.

October Courier Service on Holidays There will be no courier service Thursday, Dec. 24th, 2011. University of Washington October 2011 TEST CHANGE ACTH Aldosterone BCR/ABL by PCR, Qualitative Chlamydia trachomatis & N.gonorrhoeae, Amp. NA Creutzfeldt-Jakob, CSF Desipramine Doxepine and Nordoxepine,

More information

Original Policy Date

Original Policy Date MP 2.04.76 Genetic Counseling Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Created Local Policy/ 12:2013 Return to Medical Policy Index Disclaimer

More information

Thrombophilia. Diagnosis and Management. Kevin P. Hubbard, DO, FACOI

Thrombophilia. Diagnosis and Management. Kevin P. Hubbard, DO, FACOI Thrombophilia Diagnosis and Management Kevin P. Hubbard, DO, FACOI Clinical Professor of Medicine Kansas City University of Medicine and Biosciences-College of Osteopathic Medicine Kansas City, Missouri

More information

Specimen Type Specimen Container Transport Environment Preferred 2mL(0.5) Serum Clot Activator SST (Red/Gray or Tiger Top) Refrigerated

Specimen Type Specimen Container Transport Environment Preferred 2mL(0.5) Serum Clot Activator SST (Red/Gray or Tiger Top) Refrigerated Aldolase Order Name: ALDOLASE Test Number: 3600150 Aldolase Enz Preferred 2mL(0.5) Serum Clot Activator SST (Red/Gray or Tiger Top) Refrigerated Special Hemolyzed specimens are not acceptable. Allow specimen

More information

B.P. CLINICAL LAB SDN. BHD. ESOTERIC TEST LIST

B.P. CLINICAL LAB SDN. BHD. ESOTERIC TEST LIST B.P. CLINICAL LAB SDN. BHD. ESOTERIC TEST LIST (* updated:28/03/2017) Note: If any test(s) in esoteric list below is included in campaign profile, outlet/requester must notify processing lab at least 2-3

More information

In Office Lab Testing

In Office Lab Testing Effective January 1, 201, the lab services below can be performed and reimbursed in an office setting. All other office-based lab services must be submitted through our contracted laboratory providers.

More information

REFLEX TESTING LIST March 2012

REFLEX TESTING LIST March 2012 Aeromonas/Plesiomonas Positive findings Organism ID & Susceptibility April 2011 Culture *AFB Culture and Stain Positive findings Organism ID & Susceptibility Nov. 1999 *AFB Culture Only Positive findings

More information

In-OfficeLabTesting. Effective date: August 1, 2017

In-OfficeLabTesting. Effective date: August 1, 2017 Effective date: August 1, 2017 In-OfficeLabTesting The lab services below can be performed and reimbursed in an office setting. All other office-based lab services must be submitted through our contracted

More information

SureSelect Cancer All-In-One Custom and Catalog NGS Assays

SureSelect Cancer All-In-One Custom and Catalog NGS Assays SureSelect Cancer All-In-One Custom and Catalog NGS Assays Detect all cancer-relevant variants in a single SureSelect assay SNV Indel TL SNV Indel TL Single DNA input Single AIO assay Single data analysis

More information

No. Code TEST SPECIMEN TAT TO Aldolase 3 ml Plain Blood/Serum (10-12 hour fasting

No. Code TEST SPECIMEN TAT TO Aldolase 3 ml Plain Blood/Serum (10-12 hour fasting B.P. CLINICAL LAB SDN. BHD. ESOTERIC TEST LIST (* updated:20/03/2018) Note: If any test(s) in esoteric list below is included in campaign profile, outlet/requester must notify processing lab at least 2-3

More information

Laboratory Evaluation of Venous Thrombosis Risk

Laboratory Evaluation of Venous Thrombosis Risk Laboratory Evaluation of Venous Thrombosis Risk Dorothy M. Adcock, MD Volume 17, Number 12 December 2003 Objective: The reader will be able to discuss the concepts of risk factor, risk potential and thrombotic

More information

Recommendations for Celiac Disease Testing. IgA & ttg IgA

Recommendations for Celiac Disease Testing. IgA & ttg IgA Recommendations for Celiac Disease Testing IgA & ttg IgA IgA Normal ttg IgA Negative IgA >10 mg/dl, but less than age matched range IgA

More information

Molecular and Cellular Biology Unit School of Life Sciences Manipal University Manipal

Molecular and Cellular Biology Unit School of Life Sciences Manipal University Manipal D i a g n o s t i c Te s t s Molecular and Cellular Biology Unit Manipal University Manipal 576 104 Contact Tel: 0820 2922058; 0820 2923501 Email: dbt@manipal.edu Working Hours Monday to Saturday (9:00

More information

B.P. CLINICAL LAB SDN. BHD. ESOTERIC TEST LIST

B.P. CLINICAL LAB SDN. BHD. ESOTERIC TEST LIST B.P. CLINICAL LAB SDN. BHD. ESOTERIC TEST LIST Note: For campaign profile, please notify processing lab 3 weeks in advanced for reagent and consumables preparation. Failure to pre-notify lab will cause

More information

Targeted Molecular Diagnostics for Targeted Therapies in Hematological Disorders

Targeted Molecular Diagnostics for Targeted Therapies in Hematological Disorders Targeted Molecular Diagnostics for Targeted Therapies in Hematological Disorders Richard D. Press, MD, PhD Dept of Pathology Knight Cancer Institute Knight Diagnostic Labs Oregon Health & Science University

More information

Next generation histopathological diagnosis for precision medicine in solid cancers

Next generation histopathological diagnosis for precision medicine in solid cancers Next generation histopathological diagnosis for precision medicine in solid cancers from genomics to clinical application Aldo Scarpa ARC-NET Applied Research on Cancer Department of Pathology and Diagnostics

More information

1105 Aldolase 3 ml Plain Blood/Serum (10-12 hour fasting) 1 week NUH S'pore Alpha Thalassaemia Genotyping 3 ml EDTA blood 2-3 weeks NUH S'pore

1105 Aldolase 3 ml Plain Blood/Serum (10-12 hour fasting) 1 week NUH S'pore Alpha Thalassaemia Genotyping 3 ml EDTA blood 2-3 weeks NUH S'pore B.P. CLINICAL LAB SDN. BHD. ESOTERIC TEST LIST Note: For campaign profile, please notify processing lab 3 weeks in advanced for reagent and consumables preparation. Failure to pre-notify lab will cause

More information

Molecular. Oncology & Pathology. Diagnostic, Prognostic, Therapeutic, and Predisposition Tests in Precision Medicine. Liquid Biopsy.

Molecular. Oncology & Pathology. Diagnostic, Prognostic, Therapeutic, and Predisposition Tests in Precision Medicine. Liquid Biopsy. Molecular Oncology & Pathology Hereditary Cancer Somatic Cancer Liquid Biopsy Next-Gen Sequencing qpcr Sanger Sequencing Diagnostic, Prognostic, Therapeutic, and Predisposition Tests in Precision Medicine

More information

Best of ASCO 2014 Sarcoma

Best of ASCO 2014 Sarcoma Best of ASCO 2014 Sarcoma Robin L Jones Seattle Cancer Care Alliance University of Washington Fred Hutchinson Cancer Research Center Presentation Outline Overview progress made in sarcoma Highlight 2 trials

More information

Acetylcholine Receptor Modulating Antibody

Acetylcholine Receptor Modulating Antibody Acetylcholine Receptor Modulating Antibody Order Name: ACETY MOD Test Number: 5516500 TEST COMPONENTS REV DATE: 09/25/2012 Acetylcholine Receptor Modulating Antibody SEMI-FC Preferred 1 ml (0.5) Serum

More information

Patricia Aoun MD, MPH Professor and Vice-Chair for Clinical Affairs Medical Director, Clinical Laboratories Department of Pathology City of Hope

Patricia Aoun MD, MPH Professor and Vice-Chair for Clinical Affairs Medical Director, Clinical Laboratories Department of Pathology City of Hope Patricia Aoun MD, MPH Professor and Vice-Chair for Clinical Affairs Medical Director, Clinical Laboratories Department of Pathology City of Hope National Medical Center Disclosures I have no disclosures

More information

Diagnostic application of SNParrays to brain cancers

Diagnostic application of SNParrays to brain cancers Diagnostic application of SNParrays to brain cancers Adriana Olar 4/17/2018 No disclosures 55 yo M, focal motor seizure T2 T1-post C DIAGNOSIS BRAIN, LEFT FRONTAL LOBE, BIOPSY: - DIFFUSE GLIOMA, OLIGODENDROGLIAL

More information

Laboratory diagnosis of congenital infections

Laboratory diagnosis of congenital infections Laboratory diagnosis of congenital infections Laboratory diagnosis of HSV Direct staining Tzanck test Immunostaining HSV isolation Serology PCR Tzanck test Cell scrape from base of the lesion smear on

More information

12/10/ Immediate Action, Quest Diagnostics Nichols Institute, Valencia

12/10/ Immediate Action, Quest Diagnostics Nichols Institute, Valencia NEW TESTS Please Note: Not all test codes assigned to each assay are listed in the table of contents. Please refer to the complete listing on the page numbers indicated. Test Code Test Name Effective Date

More information

Code TEST SPECIMEN REQUIREMENT TAT Referral centre. 1 week BP GM (Specimen stability: 2-8 C for 48 hours) 3240 Anti-ds DNA 3 ml Plain Blood/Serum

Code TEST SPECIMEN REQUIREMENT TAT Referral centre. 1 week BP GM (Specimen stability: 2-8 C for 48 hours) 3240 Anti-ds DNA 3 ml Plain Blood/Serum B.P. CLINICAL LAB SDN. BHD. ESOTERIC TEST LIST Note: For campaign profile, please notify processing lab 3 weeks in advanced for reagent and consumables preparation. Failure to pre-notify lab will cause

More information

August 17, Dear Valued Client:

August 17, Dear Valued Client: August 7, 08 Re: CMS Announces 6-Month Period of Enforcement Discretion for Laboratory Date of Service Exception Policy Under the Medicare Clinical Laboratory Fee Schedule (the 4 Day Rule ) Dear Valued

More information

A007 Allergy Basic Profile (28 parameters) 5 ml Plain Blood/Serum week BPGM

A007 Allergy Basic Profile (28 parameters) 5 ml Plain Blood/Serum week BPGM B.P. CLINICAL LAB SDN. BHD. ESOTERIC TEST LIST Note: For campaign profile, please notify processing lab 3 weeks in advanced for reagent and consumables preparation. Failure to pre-notify lab will cause

More information

NeoTYPE Cancer Profiles

NeoTYPE Cancer Profiles NeoTYPE Cancer Profiles Multimethod Analysis of 25+ Hematologic Diseases and Solid Tumors Anatomic Pathology FISH Molecular The next generation of diagnostic, prognostic, and therapeutic assessment NeoTYPE

More information

MICROBIOLOGY SPECIMEN COLLECTION MANUAL

MICROBIOLOGY SPECIMEN COLLECTION MANUAL Lee Memorial Health System Lee County, FL CLINICAL LABORATORY MICROBIOLOGY SPECIMEN COLLECTION MANUAL ACID FAST CULTURE Specimen Type see Specimen Chart ACID FAST STAIN see Specimen Chart Acid Fast stain

More information

Dr Kirsten Herbert. Dr Melita Kenealy. MBBS(Hons) FRCPA FRACP. Common Blood Tests

Dr Kirsten Herbert. Dr Melita Kenealy. MBBS(Hons) FRCPA FRACP. Common Blood Tests Common Blood Tests Your Haematologist may order numerous blood and urine tests to help diagse or manage your condition. Listed below are some of the more common tests that can be ordered in a haematology

More information

Clinical Grade Genomic Profiling: The Time Has Come

Clinical Grade Genomic Profiling: The Time Has Come Clinical Grade Genomic Profiling: The Time Has Come Gary Palmer, MD, JD, MBA, MPH Senior Vice President, Medical Affairs Foundation Medicine, Inc. Oct. 22, 2013 1 Why We Are Here A Shared Vision At Foundation

More information

Personalised cancer care Information for Medical Specialists. A new way to unlock treatment options for your patients

Personalised cancer care Information for Medical Specialists. A new way to unlock treatment options for your patients Personalised cancer care Information for Medical Specialists A new way to unlock treatment options for your patients Contents Optimised for clinical benefit 4 Development history 4 Full FIND IT panel vs

More information

Thursday, February 26, :00 am. Regulation of Coagulation/Disseminated Intravascular Coagulation HEMOSTASIS/THROMBOSIS III

Thursday, February 26, :00 am. Regulation of Coagulation/Disseminated Intravascular Coagulation HEMOSTASIS/THROMBOSIS III REGULATION OF COAGULATION Introduction HEMOSTASIS/THROMBOSIS III Regulation of Coagulation/Disseminated Coagulation necessary for maintenance of vascular integrity Enough fibrinogen to clot all vessels

More information

November Monthly Update, Quest Diagnostics Nichols Institute, Valencia

November Monthly Update, Quest Diagnostics Nichols Institute, Valencia NEW TESTS Please Note: Not all test codes assigned to each assay are listed in the table of contents. Please refer to the complete listing on the page numbers indicated. Test Code Test Name Effective Date

More information

Activated Partial Thromboplastin Time (aptt)

Activated Partial Thromboplastin Time (aptt) Activated Partial Thromboplastin Time (aptt) Order Name: PTT Test Number: 1500050 REV DATE:12/26/2008 Activated Partial Thromboplastin Time (aptt) CLOT Preferred 2.7 ml Whole Blood Sodium Citrate 3.2%

More information

Thrombosis. By Dr. Sara Mohamed Abuelgasim

Thrombosis. By Dr. Sara Mohamed Abuelgasim Thrombosis By Dr. Sara Mohamed Abuelgasim 1 Thrombosis Unchecked, blood coagulation would lead to dangerous occlusion of blood vessels if the protective mechanisms of coagulation factor inhibitors, blood

More information

Overseas Referred Tests 2014

Overseas Referred Tests 2014 OVERSEAS REFERRALS Listed below are some of the tests currently being offered by CML via Quest Diagnostics and Quest Nichols Institute The fees are quoted in US$ and a JA$ handling charge is also applicable.

More information

APPLICATIONS OF NEXT GENERATION SEQUENCING IN SOLID TUMORS - PATHOLOGIST PROSPECTIVE

APPLICATIONS OF NEXT GENERATION SEQUENCING IN SOLID TUMORS - PATHOLOGIST PROSPECTIVE AMP COMPANION MEETING SYMPOSIUM AT USCAP 2015 NEXT-GENERATION OF PATHOLOGY: ROLE OF PATHOLOGIST IN NGS-BASED PERSONALIZED MEDICINE APPLICATIONS OF NEXT GENERATION SEQUENCING IN SOLID TUMORS - PATHOLOGIST

More information

TEST MENU TEST CPT CODES TAT. Chromosome Analysis Bone Marrow x 2, 88264, x 3, Days

TEST MENU TEST CPT CODES TAT. Chromosome Analysis Bone Marrow x 2, 88264, x 3, Days TEST MENU CANCER/LEUKEMIA CHROMOSOME ANALYSIS Chromosome Analysis Bone Marrow 88237 x 2, 88264, 88280 x 3, 88291 4 Days Chromosome Analysis Bone Marrow Core 88237 x 2, 88264, 88280 x 3, 88291 4 Days Chromosome

More information

Medical Laboratory Accreditation Programme

Medical Laboratory Accreditation Programme Client Client Number 121 Address PO Box 6064, Dunedin North, Dunedin, 9059 Plunket House, 472 George Street, North Dunedin, Dunedin, 9016 Telephone 03 477-6981 Fax 03 477-9160 Authorised Representative

More information

Jennifer Hauenstein Oncology Cytogenetics Emory University Hospital Atlanta, GA

Jennifer Hauenstein Oncology Cytogenetics Emory University Hospital Atlanta, GA Comparison of Genomic Coverage using Affymetrix OncoScan Array and Illumina TruSight Tumor 170 NGS Panel for Detection of Copy Number Abnormalities in Clinical GBM Specimens Jennifer Hauenstein Oncology

More information

27027 Tourney Road Valencia, CA 91355 800 421 7110 www.specialtylabs.com Test Updates November 26, 2008 Dear Colleague: We are pleased to announce the availability of two new assays for an expanded evaluation

More information

HAEMATOLOGY. Test Name Status Result Unit Reference Interval HbA1c (Glycated Haemoglobin) 5.4 % Method : HPLC Sample Type : Whole Blood EDTA

HAEMATOLOGY. Test Name Status Result Unit Reference Interval HbA1c (Glycated Haemoglobin) 5.4 % Method : HPLC Sample Type : Whole Blood EDTA Institution Report Date 25-Dec-2016 05:59 PM HAEMATOLOGY HbA1c (Glycated Haemoglobin) 5.4 % 4.5-6.0 Method : HPLC Sample Type : Whole Blood EDTA REMARKS In vitro quantitative determination of HbA1c in

More information

Interpath Laboratory, Inc. Test File Update

Interpath Laboratory, Inc. Test File Update As an Interpath customer who receives electronic results or sends electronic orders you may need to be notified when we update our Service Manual. Although we try to keep these changes to a minimum, laboratory

More information

Guidelines for management of stroke in childhood

Guidelines for management of stroke in childhood Guidelines for management of stroke in childhood A clinical syndrome typified by rapidly developing signs of focal or global disturbance of cerebral functions, lasting more than 24 hrs or leading to death,

More information

Specific Panels. Celiac disease panel. Pancreas Panel:

Specific Panels. Celiac disease panel. Pancreas Panel: Specific Panels Celiac disease panel Anti Endomysium IgA Anti Endomysium IgG Anti Gliadin IgA Anti Gliadin IgG Anti Transglutaminase IgA Anti Transglutaminase IgG Total IgA Total IgG Stool analysis +Sudan

More information

Manifestation of Antiphospholipid Syndrome among Saudi patients :examining the applicability of sapporo Criteria

Manifestation of Antiphospholipid Syndrome among Saudi patients :examining the applicability of sapporo Criteria Manifestation of Antiphospholipid Syndrome among Saudi patients :examining the applicability of sapporo Criteria Farjah H AlGahtani Associate professor,md,mph Leukemia,Lymphoma in adolescent,thromboembolic

More information

Schedule of Accreditation

Schedule of Accreditation Schedule of Accreditation Organisation Name National Virus Reference Laboratory INAB Reg No 326MT Contact Name Eimear Malone Address University College Dublin, Belfield, Dublin Contact Phone No 01-7161319

More information

Basic Metabolic Panel

Basic Metabolic Panel Basic Metabolic Panel Order Name: CHEM 8 Test Number: 2028100 REV DATE:2/5/2008 Glucose Urea Nitrogen, Blood (BUN) Creatinine Sodium Potassium Serum/Plasma Chloride Bicarbonate Calcium Anion Gap Calculated

More information

IMMEDIATE HOT LINE: Effective January 6, 2014

IMMEDIATE HOT LINE: Effective January 6, 2014 MEDICARE COVERAGE OF LABORATORY TESTING Please remember when ordering laboratory tests that are billed to Medicare/Medicaid or other federally funded programs, the following requirements apply: 1. Only

More information

December Metanephrines, Fractionated, Free, Plasma Plasminogen Activator Inhibitor Type 1 Stool Cultures and Sensitivities

December Metanephrines, Fractionated, Free, Plasma Plasminogen Activator Inhibitor Type 1 Stool Cultures and Sensitivities University of Washington December 2012 TEST change 1,25 Dihydroxy Vitamin D Frequency AFB Blood Cultures Alcohol Screen Anti Deaminated Gliadin, IgG Anti Gliadin Package Anti Mullerian Hormone Package

More information

Potpourri of Hematology Oncology. Jasmine Nabi, M.D. Oncology Associates Hall-Perrine Cancer Center at Mercy

Potpourri of Hematology Oncology. Jasmine Nabi, M.D. Oncology Associates Hall-Perrine Cancer Center at Mercy Potpourri of Hematology Oncology Jasmine Nabi, M.D. Oncology Associates Hall-Perrine Cancer Center at Mercy Lifestyle Modifications to Decrease the Risk of Colorectal Cancer Estimates for 2018 American

More information

Identification and clinical detection of genetic alterations of pre-neoplastic lesions Time for the PML ome? David Sidransky MD Johns Hopkins

Identification and clinical detection of genetic alterations of pre-neoplastic lesions Time for the PML ome? David Sidransky MD Johns Hopkins Identification and clinical detection of genetic alterations of pre-neoplastic lesions Time for the PML ome? David Sidransky MD Johns Hopkins February 3-5, 2016 Lansdowne Resort, Leesburg, VA Molecular

More information

Next Generation Sequencing in Clinical Practice: Impact on Therapeutic Decision Making

Next Generation Sequencing in Clinical Practice: Impact on Therapeutic Decision Making Next Generation Sequencing in Clinical Practice: Impact on Therapeutic Decision Making November 20, 2014 Capturing Value in Next Generation Sequencing Symposium Douglas Johnson MD, MSCI Vanderbilt-Ingram

More information

Illumina s Cancer Research Portfolio and Dedicated Workflows

Illumina s Cancer Research Portfolio and Dedicated Workflows Illumina s Cancer Research Portfolio and Dedicated Workflows Michael Sohn Clinical Sales Specialist Spain&Italy 2017 2017 Illumina, Inc. All rights reserved. Illumina, 24sure, BaseSpace, BeadArray, BlueFish,

More information

June Monthly Update, Quest Diagnostics Nichols Institute, Valencia

June Monthly Update, Quest Diagnostics Nichols Institute, Valencia June 2013 - Monthly Update, NEW TESTS Please Note: Not all test codes assigned to each assay are listed in the table of contents. Please refer to the complete listing on the page numbers indicated. Test

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK NW Thames Regional Genetics Laboratory Northwick Park Hospital Watford Road Harrow HA1 3UJ United Kingdom Contact: Caroline Sullivan Tel:

More information

CSF + serum CSF. CSF + serum. CSF + serum CSF

CSF + serum CSF. CSF + serum. CSF + serum CSF examination General: Guidelines for the microbiological diagnostics (cerebral spinal fluid diagnosis) in adults and children: Acute meningitis or encephalitis can be caused by bacteria and viruses and

More information

Precision Oncology: Experience at UW

Precision Oncology: Experience at UW Precision Oncology: Experience at UW Colin Pritchard MD, PhD University of Washington, Department of Lab Medicine WSMOS Meeting November 1, 2013 Conflict of Interest Disclosures I declare the following,

More information

Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS

Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS NF1/SPRED1 and Other RASopathy Related Conditions on Blood/Saliva NF1- only NGS testing and copy number analysis for

More information

27027 Tourney Road Valencia, CA 91355 800 421 7110 www.specialtylabs.com Test Updates February 27, 2009 Dear Colleague: Specialty Laboratories is pleased to announce the introduction of an advanced kidney

More information

Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS

Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS NF1/SPRED1 and Other RASopathy Related Conditions NF1 only NGS testing and copy number analysis for the NF1 gene (NF1

More information

What are blood clots?

What are blood clots? What are blood clots? Dr Matthew Fay GP Principal The Willows Medical Practice- Queensbury GPwSI and Co-Founder Westcliffe Cardiology Service GP Partner Westcliffe Medical Group Created 5/31/18 Dr. Matthew

More information

Prices listed correspond to institutional rates only; please contact the lab for insurance rates.

Prices listed correspond to institutional rates only; please contact the lab for insurance rates. Prices listed correspond to institutional rates only; please contact the lab for insurance rates. Genetic Test Neurofibromatosis Type 1 - NF1 and Legius syndrome SPRED1 $1400 (NF1/SPRED1 negative) 81408,

More information

March Immunoglobulins, Total (IgA, IgE, IgG, IgM) Interleukin-6 (IL6) Protein Electrophoresis, CSF. Thyrotropin Receptor Antibody

March Immunoglobulins, Total (IgA, IgE, IgG, IgM) Interleukin-6 (IL6) Protein Electrophoresis, CSF. Thyrotropin Receptor Antibody University of Washington March 2012 TEST CHANGE Alpha 1-Antitrypsin Anti-IgE Receptor Antibody Anti-Mullerian Hormone Aquaporin-4 Receptor Antibody ColoSeq - Polyposis Complement testing, C3, C4 Everolimus

More information

Diagnosis of hypercoagulability is by. Molecular markers

Diagnosis of hypercoagulability is by. Molecular markers Agenda limitations of clinical laboratories to evaluate hypercoagulability and the underlying cause for thrombosis what is the INR the lupus anticoagulant and the antiphospholipid antibody syndrome hassouna

More information

NeoTYPE Cancer Profiles

NeoTYPE Cancer Profiles NeoTYPE Cancer Profiles 30+ Multimethod Assays for Hematologic Diseases and Solid Tumors Molecular FISH Anatomic Pathology The next generation of diagnostic, prognostic, and therapeutic assessment What

More information

Prices listed correspond to institutional rates only; please contact the lab for insurance rates.

Prices listed correspond to institutional rates only; please contact the lab for insurance rates. Prices listed correspond to institutional rates only; please contact the lab for insurance rates. Genetic Test TAT ** Neurofibromatosis Type 1 - NF1 and Legius syndrome SPRED1 $1400 (NF1/SPRED1 negative)

More information

Prices listed correspond to institutional rates only; please contact the lab for insurance rates.

Prices listed correspond to institutional rates only; please contact the lab for insurance rates. Prices listed correspond to institutional rates only; please contact the lab for insurance rates. Genetic Test Neurofibromatosis Type 1 - NF1 and Legius syndrome SPRED1 $1400 (NF1/SPRED1 negative) 81408,

More information

Inherited Thrombophilia Testing. George Rodgers, MD, PhD Kristi Smock MD

Inherited Thrombophilia Testing. George Rodgers, MD, PhD Kristi Smock MD Inherited Thrombophilia Testing George Rodgers, MD, PhD Kristi Smock MD Prevalence and risk associated with inherited thrombotic disorders Inherited Risk Factor % General Population % Patients w/ Thrombosis

More information

Acid Fast Bacilli (AFB) Culture and Smear

Acid Fast Bacilli (AFB) Culture and Smear Acid Fast Bacilli (AFB) and Smear Order Name: C AFB Test Number: 6000100 Acid Fast Bacilli (AFB) and Smear Preferred 5 ml (3) Sputum Sterile Screwtop Container Room Temperature Alternate 1 5 ml (3) Tissue

More information

Atypical Pneumonia Antibodies

Atypical Pneumonia Antibodies Atypical Pneumonia Antibodies Order Name: ATYP PNEUM Test Number: 5564200 REV DATE:1/17/2011 Adenovirus IgG and IgM Antibodies Chlamydia pneumoniae IgM Antibody Chlamydia pneumoniae IgG Antibody Influenza

More information

DISCLOSURE. Presented by: Merav Sendowski, MD Oregon Health and Science University

DISCLOSURE. Presented by: Merav Sendowski, MD Oregon Health and Science University Thrombophilia! DISCLOSURE Presented by: Merav Sendowski, MD Oregon Health and Science University Created by: Thomas Deloughery, MD Oregon Health and Science University Current Relevant Financial Relationship(s)

More information

Clinical, Pathologic and Molecular Updates

Clinical, Pathologic and Molecular Updates Colorectal Cancer: Clinical, Pathologic and Molecular Updates Joanna A. Gibson, M.D./Ph.D. Yale University School of Medicine/Yale New Haven Hospital, Department of Pathology Gastrointestinal, Pancreaticobiliary

More information

Clinical Grade Biomarkers in the Genomic Era Observations & Challenges

Clinical Grade Biomarkers in the Genomic Era Observations & Challenges Clinical Grade Biomarkers in the Genomic Era Observations & Challenges IOM Committee on Policy Issues in the Clinical Development & Use of Biomarkers for Molecularly Targeted Therapies March 31-April 1,

More information